Baker Skin Field Cancerisation Tool: Clinical Validation and Correlation with Quality of Life

Not Applicable

• Conditions: Skin Cancer; Cancer - Non melanoma skin cancer

• Registration Number: ACTRN12619001584123
• Lead Sponsor: GenesisCare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-18
• Last Update Posted: 10 August 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 71

Inclusion Criteria

•Aged 18 years or older
•Attending St Vincent’s Hospital Melbourne dermatology clinics
•Informed consent for participation obtained
•Evidence of actinic damage in one or more anatomic zone
•Range of severities: no threshold for severity as the study seeks to gain experience in a range of disease presentations.
•All Fitzpatrick skin phototypes.

Exclusion Criteria

•Less than 18 years of age
•Informed consent for participation not obtained
•No actinic damage

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective of this study is to validate the Baker Skin Field Cancerisation Tool with in-vivo and photographic scoring. [In vivo assessment and scoring will occur during the participants' clinic visit. Scoring of the photographs will occur at least four (4) weeks (and no more than 8 weeks) following the clinic visit. ]